Profound Medical Corp. - Common Shares (PROF) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2025

Type / Class
Equity / Common Shares
Symbol
PROF on Nasdaq
Shares outstanding
29,881,634
Price per share
$7.48
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
15,238,347
Total reported value
$119,864,543
% of total 13F portfolios
0%
Share change
+3,983,324
Value change
+$31,389,798
Number of holders
62
Price from insider filings
$7.48
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Profound Medical Corp. - Common Shares (PROF) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GAGNON SECURITIES LLC 11% $15,796,627 3,346,743 Neil Gagnon 31 Dec 2024

As of 31 Dec 2025, 62 institutional investors reported holding 15,238,347 shares of Profound Medical Corp. - Common Shares (PROF). This represents 51% of the company’s total 29,881,634 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Profound Medical Corp. - Common Shares (PROF) together control 48% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FIL Ltd 7.4% 2,200,000 +17% 0.01% $17,269,747
GAGNON SECURITIES LLC 6.5% 1,944,061 +12% 3.1% $15,299,760
Rosalind Advisors, Inc. 3.6% 1,068,955 +54% 3.2% $8,412,676
ROYCE & ASSOCIATES LP 3.3% 990,348 +15% 0.08% $7,770,973
Timelo Investment Management Inc. 3.3% 979,967 +62% 8.2% $7,712,340
LETKO, BROSSEAU & ASSOCIATES INC 3.2% 970,675 -1.6% 0.12% $7,627,447
Gagnon Advisors, LLC 3.2% 962,186 +7.3% 4.8% $7,572,404
Alyeska Investment Group, L.P. 2.3% 678,570 0.02% $5,340,346
MMCAP International Inc. SPC 1.8% 531,362 +6.1% 0.42% $4,181,819
ROYAL BANK OF CANADA 1.6% 473,218 -2.6% 0% $3,725,000
Ring Mountain Capital, LLC 1.5% 454,080 +15% 1.9% $3,733,000
ARDSLEY ADVISORY PARTNERS LP 1.5% 450,000 +36% 0.45% $3,541,500
First Eagle Investment Management, LLC 1% 312,707 +7.3% 0% $2,461,004
ESSEX INVESTMENT MANAGEMENT CO LLC 1% 309,604 0.37% $2,436,583
DAFNA Capital Management LLC 0.96% 285,710 0.52% $2,248,538
Velan Capital Investment Management LP 0.96% 285,710 1.3% $2,248,538
Bleichroeder LP 0.85% 254,753 +39% 0.35% $2,004,906
THOMPSON DAVIS & CO., INC. 0.73% 216,735 +3.8% 1% $1,705,704
FORMULA GROWTH LTD 0.68% 202,918 0% 0.62% $1,596,965
NATIONAL BANK OF CANADA /FI/ 0.63% 189,510 +9.6% 0% $1,421,905
Empery Asset Management, LP 0.48% 143,532 0% 1% $1,129,597
RAYMOND JAMES FINANCIAL INC 0.45% 135,285 -11% 0% $1,064,693
Zweig-DiMenna Associates LLC 0.44% 130,000 0.07% $1,023,100
PERKINS CAPITAL MANAGEMENT INC 0.38% 114,280 0.71% $899,384
Connective Capital Management, LLC 0.33% 100,000 0.46% $787,000

Institutional Holders of Profound Medical Corp. - Common Shares (PROF) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 15,238,347 $119,864,543 +$31,389,798 $7.87 62
2025 Q3 11,063,194 $54,283,775 -$7,406,922 $4.89 43
2025 Q2 12,482,340 $73,650,616 -$2,042,016 $5.90 44
2025 Q1 12,825,851 $73,303,109 -$7,205,786 $5.82 48
2024 Q4 13,763,555 $102,960,287 +$30,141,003 $7.51 51
2024 Q3 9,406,781 $74,869,184 -$1,117,706 $7.96 42
2024 Q2 9,510,240 $80,047,787 -$132,453 $8.39 37
2024 Q1 9,500,142 $80,114,995 +$2,238,848 $8.53 39
2023 Q4 9,251,176 $77,759,535 +$10,244,275 $8.49 45
2023 Q3 7,489,374 $75,450,155 -$1,487,679 $10.20 30
2023 Q2 7,634,234 $98,724,050 -$1,129,044 $13.01 29
2023 Q1 7,726,121 $71,704,219 -$6,964,776 $9.29 30
2022 Q4 8,472,949 $91,726,796 +$3,083,523 $10.89 33
2022 Q3 8,745,198 $35,381,959 -$177,655 $4.04 30
2022 Q2 8,675,590 $63,032,248 -$3,670,846 $7.29 34
2022 Q1 9,402,835 $84,635,691 -$3,611,432 $9.00 41
2021 Q4 9,774,988 $109,777,858 -$2,915,423 $11.24 44
2021 Q3 8,722,358 $127,589,352 -$1,309,423 $14.64 46
2021 Q2 8,722,951 $142,593,346 -$126,994 $16.36 46
2021 Q1 8,673,835 $174,440,609 +$8,178,699 $20.14 52
2020 Q4 8,182,487 $168,377,436 +$26,332,305 $20.56 53
2020 Q3 7,009,150 $123,510,789 +$42,298,243 $17.64 44
2020 Q2 4,612,581 $78,146,000 -$131,017 $16.94 33
2020 Q1 4,764,927 $46,182,000 +$27,289,444 $9.74 31
2019 Q4 1,948,600 $21,824,000 +$21,824,000 $10.98 16